Literature DB >> 14645675

Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice.

Nicole Struckmann1, Sandra Schwering, Silke Wiegand, Anja Gschnell, Masahisa Yamada, Wolfgang Kummer, Jürgen Wess, Rainer V Haberberger.   

Abstract

In the airways, increases in cholinergic nerve activity and cholinergic hypersensitivity are associated with chronic obstructive pulmonary disease and asthma. However, the contribution of individual muscarinic acetylcholine receptor subtypes to the constriction of smaller intrapulmonary airways that are primarily responsible for airway resistance has not been analyzed. To address this issue, we used videomicroscopy and digital imaging of precision-cut lung slices derived from wild-type mice and mice deficient in either the M1 (mAChR1-/- mice), M2 (mAChR2-/- mice), or M3 receptor subtype (mAChR3-/- mice) or lacking both the M2 and M3 receptor subtypes (mAChR2/3-/- double-knockout mice). In peripheral airways from wild-type mice (mAChR+/+ mice), muscarine induced a triphasic concentration-dependent response, characterized by an initial constriction, a transient relaxation, and a sustained constriction. The bronchoconstriction was diminished by up to 60% in mAChR3-/- lungs and was completely abolished in mAChR2/3-/- lungs. The sustained bronchoconstriction was reduced in mAChR2-/- bronchi, and, interestingly, the transient relaxation was absent; the bronchoconstriction in response to 10-8 M muscarine was increased by 158% in mAChR1-/- mice. Quantitative reverse transcriptase-polymerase chain reaction analysis revealed that the disruption of specific mAChR genes had no significant effect on the expression levels of the remaining mAChR subtypes. These results demonstrate that cholinergic constriction of murine peripheral airways is mediated by the concerted action of the M2 and M3 receptor subtypes and suggest the existence of pulmonary M1 receptor activation, which counteracts cholinergic bronchoconstriction. Given the important role of muscarinic cholinergic mechanisms in pulmonary disease, these findings should be of considerable therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645675     DOI: 10.1124/mol.64.6.1444

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  46 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy.

Authors:  Stuart B Mazzone; Nanako Mori; Miriam Burman; Michael Palovich; Kristen E Belmonte; Brendan J Canning
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

3.  M(2) and M(3) muscarinic receptor-mediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice.

Authors:  Toshihiro Unno; Hayato Matsuyama; Takashi Sakamoto; Mai Uchiyama; Yusuke Izumi; Hiroyuki Okamoto; Masahisa Yamada; Jürgen Wess; Seiichi Komori
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice.

Authors:  Anne-Ulrike Trendelenburg; Angelika Meyer; Jürgen Wess; Klaus Starke
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 5.  Regulation of heterotrimeric G protein signaling in airway smooth muscle.

Authors:  Raymond B Penn; Jeffrey L Benovic
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

6.  Beta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscle.

Authors:  Deepak A Deshpande; Barbara S Theriot; Raymond B Penn; Julia K L Walker
Journal:  FASEB J       Date:  2008-03-12       Impact factor: 5.191

7.  Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation.

Authors:  Dennis W McGraw; Jean M Elwing; Kevin M Fogel; Wayne C H Wang; Clare B Glinka; Kathryn A Mihlbachler; Marc E Rothenberg; Stephen B Liggett
Journal:  J Clin Invest       Date:  2007-04-05       Impact factor: 14.808

8.  Exploiting functional domains of GRK2/3 to alter the competitive balance of pro- and anticontractile signaling in airway smooth muscle.

Authors:  Deepak A Deshpande; Huandong Yan; Kok-Choi Kong; Brian C Tiegs; Sarah J Morgan; Tonio Pera; Reynold A Panettieri; Andrea D Eckhart; Raymond B Penn
Journal:  FASEB J       Date:  2013-10-16       Impact factor: 5.191

9.  CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.

Authors:  Silvia Jiménez-Morales; Juan Luis Jiménez-Ruíz; Blanca Estela Del Río-Navarro; Efraín Navarro-Olivos; Guillermo Escamilla-Guerrero; Ram Savan; Michael Dean; Lorena Orozco
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

10.  Multiple muscarinic pathways mediate the suppression of voltage-gated Ca2+ channels in mouse intestinal smooth muscle cells.

Authors:  Yasuyuki Tanahashi; Toshihiro Unno; Hayato Matsuyama; Toshiaki Ishii; Masahisa Yamada; Jürgen Wess; Seiichi Komori
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.